Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APTO | KALA | NRBO | ||
| Company | Aptose Bioscns | Kala Bio Inc | Neurobo Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1900 | 6.83 | 3.67 | ||
| High | 1.2300 | 7.01 | 3.80 | ||
| Low | 1.1900 | 6.78 | 3.60 | ||
| Last | 1.2000 | 7.01 | 3.78 | ||
| Change | +0.0100 | +0.25 | +0.05 | ||
| % Change | +0.84% | +3.74% | +1.34% | ||
| Volume | 30,900 | 4,500 | 22,100 | ||
| 20-Day Average Volume | 56,460 | 10,955 | 26,485 | ||
| Previous Close | 1.1900 | 6.75 | 3.73 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2710 | 6.84 | 3.43 | ||
| 20-Day Raw Stochastic | 13.51% | 51.96% | 80.61% | ||
| 20-Day Relative Strength | 35.90% | 48.66% | 49.55% | ||
| Weighted Alpha | -86.45 | -51.71 | -44.48 | ||
| Today's Opinion | 100% Sell | 56% Sell | 24% Sell | ||
| Previous Opinion | 100% Sell | 72% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 8% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.64% since 04/26/24 | +11.23% since 04/26/24 | +20.38% since 04/26/24 | ||
| Low | 1.1800 on 04/29/24 | 6.35 on 04/29/24 | 3.10 on 04/29/24 | ||
| High | 1.2500 on 04/29/24 | 7.09 on 05/01/24 | 3.80 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -16.67% since 04/03/24 | -9.93% since 04/03/24 | -2.83% since 04/03/24 | ||
| Low | 1.1500 on 04/25/24 | 6.15 on 04/22/24 | 2.99 on 04/24/24 | ||
| High | 1.5600 on 04/04/24 | 8.01 on 04/04/24 | 4.04 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | -40.00% since 02/02/24 | +0.68% since 02/02/24 | -26.32% since 02/02/24 | ||
| Low | 1.1500 on 04/25/24 | 6.15 on 04/22/24 | 2.99 on 04/24/24 | ||
| High | 2.2000 on 02/07/24 | 8.23 on 02/22/24 | 6.75 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | -59.87% since 11/03/23 | +0.11% since 11/03/23 | +12.50% since 11/03/23 | ||
| Low | 1.1500 on 04/25/24 | 5.10 on 11/14/23 | 2.90 on 01/23/24 | ||
| High | 3.3200 on 11/10/23 | 10.97 on 12/05/23 | 6.75 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,862 | 19,736 | 18,545 | ||
| Shares Outstanding, K | 15,718 | 2,816 | 4,906 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -51,210,000 | -42,200,000 | -12,470,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -11,960,000 | -8,630,000 | -5,310,000 | ||
| 60-Month Beta | 1.36 | -1.75 | -0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.44 on 03/26/24 | -3.18 on 03/29/24 | -0.72 on 11/13/23 | ||
| Latest Earnings Date | 05/13/24 | 05/14/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||